ArticleHormones (Athens, Greece)2026
The STROBE guidelines and the Αristotelian mesotes curve.
Article in Hormones (Athens, Greece), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines aim to improve the reporting of observational studies, including cohort, case-control, and cross-sectional designs, relevant to assessing associations, risks, and outcomes in real-world clinical settings. They are conceived to optimize the meaningfulness of epidemiological and clinical studies, aligning them with the Aristotelian "mesotes" curve, namely, the principle of achieving balance and avoiding extremes to best reflect the most truthful approximation of reality. This commentary addresses situations where strict adherence to STROBE guidelines may be impossible or inappropriate, potentially distorting results, and shows how statistical tools can mitigate these issues. Specific challenges arise in real-life randomization scenarios, situations lacking placebo arms, and in correcting for multiple comparisons. We discuss these challenges, examine the role of Bonferroni and similar corrections, and propose alternative approaches such as false discovery rate (FDR) and Bayesian hierarchical models. We illustrate these points with examples from the literature and a simulation study evaluating p-value adjustments in multiple hypothesis testing. This work provides a framework for researchers to navigate STROBE guidelines thoughtfully, ensuring that observational studies are both rigorous and relevant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.